SciELO - Scientific Electronic Library Online

 
vol.73 issue2In vitro antibacterial activity of hydroethanolic extract from Myrciaria dubia (Kunth) McVaugh (camu camu) against Streptococcus mutansFactors associated with enterobiosis in children of the Ese'Eja native communities in department of Madre de Dios, Peru author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina Tropical

Print version ISSN 0375-0760On-line version ISSN 1561-3054

Abstract

SUAREZ-ALFARO, Harold. Antiretroviral therapy schemes and their cost for the health system in Colombia. Rev Cubana Med Trop [online]. 2021, vol.73, n.2, e589.  Epub Aug 01, 2021. ISSN 0375-0760.

Introduction:

Human immunodeficiency virus infection is a pandemic with a health, social and economic impact. Antiretroviral therapy is the only effective alternative to treat patients. Supply of such a therapy poses a great economic burden to health systems in low-income countries.

Objective:

Describe the antiretroviral therapy schemes formulated and their economic impact on the Colombian health system.

Methods:

A descriptive cross-sectional study and secondary source review were conducted. The study sample was 446 adult patients of both sexes with a confirmed diagnosis who attended control sessions in a specialized clinic in the city of Villavicencio, Colombia, in the year 2018. The variables analyzed were demographic characteristics, laboratory results, antiretroviral therapy formulated and cost of each scheme.

Results:

The population studied was mostly male, with a mean age of 35.8 years. 56% of the patients were under appropriate virological control. Fifteen different antiretroviral therapy schemes were found. The economic cost of each scheme ranged between 74 dollars / month and 467 dollars / month.

Conclusions:

The antiretroviral therapy formulation complies with the recommendations contained in the Colombian guide. However, it does not achieve optimal virological control and poses a high economic cost to the Colombian health care system.

Keywords : infection; HIV; costs; antiretroviral therapy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )